Centene Corp Boosted its FY23 Guidances for Adj EPS to $6.60 (Prior $6.45) Vs. $6.5 Est. and Premium and Services Revenues by $500M Vs. $148.5B Est, Announced the $1.2B Divestiture of Circle Health
Portfolio Pulse from Benzinga Newsdesk
Centene Corp has increased its FY23 guidances for adjusted EPS to $6.60, up from the previous $6.45, and above the estimated $6.5. The company also raised its premium and services revenues by $500M, against the estimated $148.5B. Additionally, Centene announced the divestiture of Circle Health for $1.2B.
October 24, 2023 | 10:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Centene's raised FY23 guidance and divestiture of Circle Health could potentially boost its stock in the short term.
The raised guidance indicates that Centene is expecting better financial performance than previously anticipated. This, along with the divestiture of Circle Health, could make the company more attractive to investors, potentially leading to a rise in its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100